Lum Cheemun, Stys Peter K, Hogan Matthew J, Nguyen Thanh B, Srinivasan Ashok, Goyal Mayank
Department of Diagnostic Imaging-Neuroradiology Section, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
Can J Neurol Sci. 2006 May;33(2):217-22. doi: 10.1017/s0317167100005011.
Different strategies have been employed to recanalize acutely occluded middle cerebral and internal carotid arteries (ICA) in the setting of acute stroke including intravenous and intra-arterial tPA. However, pharmaceutical thrombolysis alone, may not be effective in patients with a large amount of clot volume (complete M1, terminal internal carotid artery). We report our initial experience with endovascular clot disruption using a soft silicone balloon in addition to intravenous or intra-arterial thrombolysis with tPA.
This is a retrospective review of nine patients with symptoms of acute stroke from clot in the middle cerebral or internal carotid territories who were treated with intracranial balloon angioplasty. All patients presented with symptoms of acute anterior circulation stroke less than six hours from onset. Patients in whom computed tomography (CT) angiography confirmed the presence of large vessel clot (terminal ICA, M1 or proximal M2) were included in the study. A CT perfusion was performed providing maps of cerebral blood volume, flow and mean transit time. If the patient presented less than three hours from onset then intravenous tissue plasminogen activator (tPA) was also administered. Intra-arterial tPA was delivered into the clot. If the volume of clot was judged to be significant by the treating neurointerventionist, then a limited trial of tPA was administered intra-arterially followed by balloon angioplasty of persistant clot. The time from imaging to vessel recanalization was recorded. Clinical outcomes were assessed using the modified Rankin scale and Barthel Index.
Diagnostic CT perfusion studies were performed in 7 (78%), all of which showed a significant amount of salvageable tissue as judged by the treating neurointerventionist and neurologist. Recanalization (TIMI 2 or 3) was possible in 8 (89%). There were no cases of symptomatic intracranial hemorrhage and 2 (22%) asymptomatic hemorrhages. The average time from performance of the initial emergency CT to vessel recanalization was 2.1 hours with mean time from symptom onset to vessel recanalization of 4.1 hours. Five (56%) patients had good outcomes, 1 (11%) had mild and 3 (33%) had moderate to severe disability.
Clot angioplasty can potentially shorten recanalization times in well-selected patients and can be an effective complimentary procedure in patients with tPA resistant clot. Angioplasty can be performed with a very low complication rate using the technique described and may be associated with good outcomes.
在急性卒中的情况下,已经采用了不同的策略来使急性闭塞的大脑中动脉和颈内动脉(ICA)再通,包括静脉内和动脉内使用组织型纤溶酶原激活剂(tPA)。然而,单独的药物溶栓可能对血栓体积较大的患者(M1段完全闭塞、颈内动脉末端闭塞)无效。我们报告了在静脉或动脉内使用tPA溶栓的基础上,使用柔软硅胶球囊进行血管内血栓破碎的初步经验。
这是一项对9例大脑中动脉或颈内动脉区域血栓形成导致急性卒中症状的患者进行的回顾性研究,这些患者接受了颅内球囊血管成形术治疗。所有患者均在发病后6小时内出现急性前循环卒中症状。计算机断层扫描(CT)血管造影证实存在大血管血栓(颈内动脉末端、M1段或M2段近端)的患者被纳入研究。进行了CT灌注检查,提供脑血容量、血流和平均通过时间图。如果患者发病时间少于3小时,则也给予静脉注射组织型纤溶酶原激活剂(tPA)。将动脉内tPA注入血栓。如果治疗的神经介入医生判断血栓体积较大,则先进行有限剂量的动脉内tPA治疗,然后对持续存在的血栓进行球囊血管成形术。记录从成像到血管再通的时间。使用改良Rankin量表和Barthel指数评估临床结局。
7例(78%)患者进行了诊断性CT灌注研究,治疗的神经介入医生和神经科医生判断所有这些研究均显示有大量可挽救的组织。8例(89%)实现了再通(TIMI 2级或3级)。没有出现症状性颅内出血病例,2例(22%)为无症状性出血。从最初的急诊CT检查到血管再通的平均时间为2.1小时,从症状发作到血管再通的平均时间为4.1小时。5例(56%)患者预后良好,1例(11%)轻度残疾,3例(33%)中度至重度残疾。
对于精心挑选的患者,血栓血管成形术可能会缩短再通时间,并且对于对tPA耐药的血栓患者可能是一种有效的辅助治疗方法。使用所述技术进行血管成形术的并发症发生率非常低,并且可能与良好的预后相关。